Skip to main content

Animations

MJFF Publications

7851 - 7860 of 8818 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2023
  • 2023
  • 2019
  • 2019
  • 2019
  • 2023
  • Summary Details
    OPEN
    Title: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-019-01993-2
    Citation Count: 76
  • Summary Details
    OPEN
    Title: Increased Cortical Thickness in Attentional Networks in Parkinson’s Disease with Minor Hallucinations
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2019/5351749
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician Interviews
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0215384
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-42535-w
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Proteome census upon nutrient stress reveals Golgiphagy membrane receptors
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-023-06657-6
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-42626-3
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-019-0457-5
    Citation Count: 242
  • Summary Details
    OPEN
    Title: Genetic risk of Parkinson disease and progression:
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000348
    Citation Count: 148
  • Summary Details
    OPEN
    Title: MAPT p.V363I mutation
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000347
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Free water imaging unravels unique patterns of longitudinal structural brain changes in Parkinson’s disease subtypes
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2023.1278065
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.